Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC
Itziar Otano, Álvaro C. Ucero, Jon Zugazagoitia, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 143-159
Closed Access | Times Cited: 73
Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma
Gao Shan, Minchao Kang, Wang Jizhao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 229, pp. 115346-115346
Closed Access | Times Cited: 25
New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation
Li Zhang, Li-Yue Xu, Fei Tang, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 6, pp. 100930-100930
Open Access | Times Cited: 11
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner
Xuan Du, Cheng Cheng, Yi Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 962-976
Closed Access | Times Cited: 6
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes
Tianyu Zhang, Jie Yang, Sijian Li, et al.
Journal of Gynecologic Oncology (2025) Vol. 36
Open Access
GTF2I acts as a novel tumor suppressor transcription factor and shows Favorable prognosis in renal cancer
Tikam Chand Dakal, Mony Thakur, Nancy George, et al.
Integrative Biology (2025) Vol. 17
Closed Access
Special Issue “Molecular Advances and Perspectives of Lung Disease”
Jiacheng Jiang, Longshuang Huang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 946-946
Open Access
Multi-Omics Analysis Reveals Immune Infiltration and Clinical Significance of Phosphorylation Modification Enzymes in Lung Adenocarcinoma
Deyu Long, Yanheng Ding, Peng Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1066-1066
Open Access
GRHL3 drives radiotherapy resistance and blocks the anti-tumor response of NK and CD4+ T cells in lung squamous cell carcinoma via RNF2
Haijun Wang, Changjiang Liu, Chao Jiang, et al.
Biochemical Pharmacology (2025), pp. 116784-116784
Closed Access
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma
Linlin Zhou, Tao Zhang, Yun Xue, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations
Inga Trulson, Frank Klawonn, Joachim von Pawel, et al.
Tumor Biology (2024) Vol. 46, Iss. s1, pp. S81-S98
Open Access | Times Cited: 5
Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine
Josephine A. Taverna, Chia‐Nung Hung, Madison Williams, et al.
Lung Cancer (2024) Vol. 190, pp. 107533-107533
Closed Access | Times Cited: 5
Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: a systematic review
Minyu Cheng, Yanfei Shao, Li Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
Christopher E. Whitehead, Elizabeth K. Ziemke, Christy L. Frankowski-McGregor, et al.
Nature Cancer (2024) Vol. 5, Iss. 8, pp. 1250-1266
Open Access | Times Cited: 4
An In Vitro Antimicrobial, Anticancer and Antioxidant Activity of N–[(2–Arylmethylthio)phenylsulfonyl]cinnamamide Derivatives
Anita Bułakowska, Jarosław Sławiński, Rafał Hałasa, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3087-3087
Open Access | Times Cited: 12
Using Cross Entropy as a Performance Metric for Quantifying Uncertainty in DNN Image Classifiers: An Application to Classification of Lung Cancer on CT Images
Eri Matsuyama, Masayuki Nishiki, Noriyuki Takahashi, et al.
Journal of Biomedical Science and Engineering (2024) Vol. 17, Iss. 01, pp. 1-12
Open Access | Times Cited: 4
A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of STAT3 and negative regulation of JAK2-STAT3 pathway
Fan Cao, Mengru Li, Weijie Wang, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116068-116068
Closed Access | Times Cited: 3
Cellular Senescence in Non-Small Cell Lung Cancer
Huangkai Zhu, Jiaen Sun, Chong Zhang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 357-357
Open Access | Times Cited: 9
Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis
Huan Xu, Xuanyang Wang, Xiaoqing Xu, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 12, pp. 2493-2502
Open Access | Times Cited: 8
Identification and prognostic analysis of ferroptosis‑related gene HSPA5 to predict the progression of lung squamous cell carcinoma
Di Guo, Yonghai Feng, Peijie Liu, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 2
The application of Raman spectroscopy for the diagnosis and monitoring of lung tumors
Yuyang Miao, Lihong Wu, Junlian Qiang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification
Shuming Song, Ruijiao Lu, Y. Chen, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway
Lintao Wang, Wu Luo, Suya Zhang, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 12, pp. 1385-1399
Closed Access | Times Cited: 2
Inflammatory factors and risk of lung adenocarcinoma: a Mendelian randomization study mediated by blood metabolites
Zheng Ding, Juan Chen, Bohan Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
Bo Gao, Rui Li, Song Xiao-jia, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 313-323
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top